Skip to main content
. 2022 Oct 31;17(1):1724–1741. doi: 10.1515/med-2022-0585

Figure 2.

Figure 2

Analysis of the expression of ASAP3 in the survival of glioma patients. (a) The expression of ASAP3 in the OS of glioma patients. (b) The expression of ASAP3 in the DFS of glioma patients.